Technical420 Site Search

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) a marketplace platform for cannabis and wellness products, is pleased to provide the following corporate updates. Namaste is pleased to announce that its wholly-owned subsidiary, CannMart Inc. (“CannMart”) has expanded its product offering to both our provincial customers who sell to recreational…

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath bombs, both of which are…

Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) has launched its new product line, SYNC™ Tabs, an innovative, naturally-flavoured ingestible offering consumers a controlled 10 mg THC dose with predictable onset and offset. This product line expands its offering under its SYNC™ Wellness brand and is the second of Emerald's…

The market did not respond favorably to Aphria’s (APHA.TO) (APHA) third quarter earnings report and the stock cratered almost 15%. This morning, leading Canadian broker-dealer Canaccord Genuity downgraded Aphria from Speculative Buy to Hold. The company also received a price target cut from Stifel from $22 to $18 (CAD). Going…

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”). “Although Q2 2021 results were challenged by industry dynamics, COVID-19 and staffing limitations…

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company”), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (CVD), today announced topline results from a Phase I single and multiple ascending dose clinical trial of CardiolRx™, a pharmaceutically produced oral cannabidiol formulation…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced it has appointed Dr. Jason Dyck as its new Chief Science Officer, and Chairman of its Scientific Advisory Board. (SAB). The appointment is in line with the Company's strategy to leverage the roots of its management team in medical cannabis, and…

Today, Aphria Inc. (TSX: APHA) (NASDAQ: APHA) released third quarter financial and operating results for the period that ended on February 28, 2021.  This is expected to be Aphria’s final earnings report as a standalone company and find this to be significant. In the near future, the pending mega-merger with…

So far, one of the biggest stories in the cannabis industry is related to the pending merger of Aphria Inc. (APHA.TO) (APHA).  Earlier this morning, Tilray filed a  Schedule 14A with the United States Securities and Exchange Commission (SEC) after social media communications were posted on platforms like Twitter (TWTR)…

 Aphria Inc. (" Aphria ," " we ," or the " Company ") (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended…